Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
NASDAQ:XENT
Price:
28.24 USD
Market Closed
Updated:
May 21, 2024
P/E
Price to Earnings
Price to Earnings
-5.7
Current
-5.7
Median
24.1
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-5.7
Market Cap
/
954.8m
Net Income
-168.4m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Intersect Ent Inc
NASDAQ:XENT
|
954.8m USD | -5.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
179.5B USD | 31.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.9B USD | 71.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.6B USD | 37.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.4B USD | 26.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.8B USD | 62.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.9B USD | 52.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 32.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54B USD | 38.2 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.8B USD | 81 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
369.6B CNY | 30.4 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-17.2
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
